MAPS founder Rick Doblin charts psychedelics' journey from CIA mind-control experiments to FDA-track MDMA therapy that crushed PTSD in a phase 3 trial.

Rick Doblin — Founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), a nonprofit pharmaceutical organization. A seminal figure in psychedelic research and policy who has spent ~49 years working to legalize and medicalize substances like MDMA and psilocybin.
Rick Doblin gives Lex Fridman a sweeping tour of psychedelics, from the classic ego-dissolving compounds (LSD, psilocybin, DMT) to MDMA, framing them as tools that reveal what is already within us rather than conjuring something new. He recounts the cultural history including the CIA's MK-Ultra program, Timothy Leary, and Ken Kesey, and explains how MAPS was built as a nonprofit pharma to make MDMA-assisted therapy a real medicine. The centerpiece is the phase 3 MDMA-for-PTSD trial published in Nature Medicine, which showed extraordinary statistical significance and helped even the hardest cases. Doblin lays out a roadmap toward FDA approval and eventual licensed legalization, while warning about for-profit pharma optimizing for sales over patient outcomes. He closes with reflections on trauma, death, meaning, and advice to find what makes you come alive.